These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

852 related articles for article (PubMed ID: 18425818)

  • 1. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine.
    Stresemann C; Lyko F
    Int J Cancer; 2008 Jul; 123(1):8-13. PubMed ID: 18425818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy.
    Christman JK
    Oncogene; 2002 Aug; 21(35):5483-95. PubMed ID: 12154409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methyltransferase inhibitors for cancer therapy.
    Brueckner B; Kuck D; Lyko F
    Cancer J; 2007; 13(1):17-22. PubMed ID: 17464242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic drug discovery: targeting DNA methyltransferases.
    Foulks JM; Parnell KM; Nix RN; Chau S; Swierczek K; Saunders M; Wright K; Hendrickson TF; Ho KK; McCullar MV; Kanner SB
    J Biomol Screen; 2012 Jan; 17(1):2-17. PubMed ID: 21965114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decitabine.
    Daskalakis M; Blagitko-Dorfs N; Hackanson B
    Recent Results Cancer Res; 2010; 184():131-57. PubMed ID: 20072836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
    Cowan LA; Talwar S; Yang AS
    Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
    Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
    BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dna methylation by 5-aza-2'-deoxycytidine correlates with induction of K562 cells differentiation.
    Fabianowska-Majewska K; Wyczechowska D; Czyz M
    Adv Exp Med Biol; 2000; 486():343-7. PubMed ID: 11783512
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
    Lyko F; Brown R
    J Natl Cancer Inst; 2005 Oct; 97(20):1498-506. PubMed ID: 16234563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will next-generation agents deliver on the promise of epigenetic hypomethylation therapy?
    Lowder JN; Taverna P; Issa JP
    Epigenomics; 2015 Oct; 7(7):1083-8. PubMed ID: 26541345
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.
    Hummel-Eisenbeiss J; Hascher A; Hals PA; Sandvold ML; Müller-Tidow C; Lyko F; Rius M
    Mol Pharmacol; 2013 Sep; 84(3):438-50. PubMed ID: 23814180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demethylation of DNA by decitabine in cancer chemotherapy.
    Brown R; Plumb JA
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):501-10. PubMed ID: 15270655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
    Zhou Z; Li HQ; Liu F
    Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2'-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: a novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1.
    Byun HM; Choi SH; Laird PW; Trinh B; Siddiqui MA; Marquez VE; Yang AS
    Cancer Lett; 2008 Aug; 266(2):238-48. PubMed ID: 18499340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decitabine. MGI Pharma Inc/SuperGen Inc.
    Arthur C
    IDrugs; 2004 Dec; 7(12):1113-32. PubMed ID: 15599805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs.
    Murgo AJ
    Semin Oncol; 2005 Oct; 32(5):458-64. PubMed ID: 16210086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digging deep into "dirty" drugs - modulation of the methylation machinery.
    Pleyer L; Greil R
    Drug Metab Rev; 2015 May; 47(2):252-79. PubMed ID: 25566693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines.
    Schaefer M; Hagemann S; Hanna K; Lyko F
    Cancer Res; 2009 Oct; 69(20):8127-32. PubMed ID: 19808971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells.
    Flotho C; Claus R; Batz C; Schneider M; Sandrock I; Ihde S; Plass C; Niemeyer CM; Lübbert M
    Leukemia; 2009 Jun; 23(6):1019-28. PubMed ID: 19194470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation and gene silencing in cancer.
    Baylin SB
    Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S4-11. PubMed ID: 16341240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.